News
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...
Clinical Trials Arena on MSN19h
Rallybio drops drug for rare maternal disorder following Phase II failUS-based biotech Rallybio is ending its RLYB212 programme for the prevention of fetal and neonatal alloimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback